Plain-English translation of NCT06276374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a carotid artery stent is placed (a small tube inserted into a narrowed artery in your neck), patients typically take two blood-thinning medications together to prevent clots and strokes. This trial is testing whether people at high risk of bleeding can safely take just one of these medications—either aspirin or clopidogrel—for 11 months after their stent, instead of continuing both. The goal is to reduce bleeding complications while still protecting against stroke.
People at high risk of bleeding face a difficult choice after getting a carotid stent: taking two blood thinners reduces their stroke risk but increases their risk of dangerous bleeding. This trial aims to find out whether using just one blood thinner medication might offer a safer balance for these patients, preventing both strokes and serious bleeding events.
You likely qualify if…
You likely don't qualify if…
After your carotid stent is placed, you'll take two blood thinner medications together for 30 days. If you have no complications during this month, you'll be randomly assigned to either continue both medications or switch to taking just one for the next 11 months. You'll have follow-up appointments at 5 months and 11 months after this assignment, and then annual check-ins by phone or office visit until the end of 2029. The study team will monitor you for any signs of bleeding or stroke throughout this time.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
South Korea